Kalyaani Persad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kalyaani Persad has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Punith Kempegowda
Department of Applied Health Sciences, School of Health Sciences, College of Medicine and Health University of Birmingham Birmingham UK
5 shared publications - Aspasia Manta
Department of Applied Health Sciences, School of Health Sciences, College of Medicine and Health University of Birmingham Birmingham UK
3 shared publications - Amanda Ling Jie Yee
Department of Applied Health Sciences, School of Health Sciences, College of Medicine and Health University of Birmingham Birmingham UK
2 shared publications - Aqeelah Khatoon
Good Hope Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
2 shared publications - Nevil C. Philip
Department of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK
2 shared publications - Aashritha Buchipudi
Birmingham Medical School, School of Medical Sciences, University of Birmingham Birmingham UK
1 shared publication
Latest Publications
- Open Access
- 9 November 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
Diabetic Ketoacidosis: Systematic Review and Meta‐Analysis
Aims: Diabetic ketoacidosis (DKA) remains a major cause of diabetes‐related morbidity and mortality worldwide, yet evidence on its management and clinical outcomes across healthcare settings remains limited. We conducted a systematic review and meta‐analysis to evaluate the precipitants, management and outcomes of adult DKA. Materials and Methods: We searched PubMed, Embase, Web of Science, Scopus, MEDLINE, CINAHL and ERIC from 2000 to April 2026 for studies reporting precipitating factors, management and outcomes among adults (≥ 16 years) with DKA. Articles that did not report all three were excluded. Two reviewers independently screened studies, extracted data and assessed risk of bias. Descriptive synthesis was performed for demographic, biochemical, management and outcome variables. A random‐effects meta‐analysis estimated summary in‐hospital all‐cause mortality. This review was registered with PROSPERO (ID: CRD42025641665). https://www.crd.york.ac.uk/PROSPERO/view/CRD42025641665 . Results: Nineteen studies met the inclusion criteria, of which 15 studies comprising 1278 DKA episodes contributed to the descriptive synthesis and nine studies including 724 participants to the mortality meta‐analysis. Most episodes were classified as moderate or severe DKA. Preadmission glycaemic control was frequently suboptimal. Missed or inadequate diabetes medication was the commonest precipitant (42.2%), followed by infection (28.6%) and newly diagnosed diabetes (11.2%). Substantial regional variation was observed in guideline use, insulin and fluid administration, intensive care admission and treatment‐related complications. The in‐hospital mortality summary estimate was 2.17% (95% CI, 0.93%–4.99%). Conclusion: Medication omission and infection remain the dominant precipitants of adult DKA worldwide. Marked variation in management practices and outcomes persists across healthcare systems, suggesting inconsistent implementation of DKA care pathways.
- 9 November 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
Open AccessDiabetic Ketoacidosis: Systematic Review and Meta‐Analysis
Aims: Diabetic ketoacidosis (DKA) remains a major cause of diabetes‐related morbidity and mortality worldwide, yet evidence on its management and clinical outcomes across healthcare settings remains limited. We conducted a systematic review and meta‐analysis to evaluate the precipitants, management and outcomes of adult DKA. Materials and Methods: We searched PubMed, Embase, Web of Science, Scopus, MEDLINE, CINAHL and ERIC from 2000 to April 2026 for studies reporting precipitating factors, management and outcomes among adults (≥ 16 years) with DKA. Articles that did not report all three were excluded. Two reviewers independently screened studies, extracted data and assessed risk of bias. Descriptive synthesis was performed for demographic, biochemical, management and outcome variables. A random‐effects meta‐analysis estimated summary in‐hospital all‐cause mortality. This review was registered with PROSPERO (ID: CRD42025641665). https://www.crd.york.ac.uk/PROSPERO/view/CRD42025641665 . Results: Nineteen studies met the inclusion criteria, of which 15 studies comprising 1278 DKA episodes contributed to the descriptive synthesis and nine studies including 724 participants to the mortality meta‐analysis. Most episodes were classified as moderate or severe DKA. Preadmission glycaemic control was frequently suboptimal. Missed or inadequate diabetes medication was the commonest precipitant (42.2%), followed by infection (28.6%) and newly diagnosed diabetes (11.2%). Substantial regional variation was observed in guideline use, insulin and fluid administration, intensive care admission and treatment‐related complications. The in‐hospital mortality summary estimate was 2.17% (95% CI, 0.93%–4.99%). Conclusion: Medication omission and infection remain the dominant precipitants of adult DKA worldwide. Marked variation in management practices and outcomes persists across healthcare systems, suggesting inconsistent implementation of DKA care pathways.
- Open Access
- 3 November 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
Closed‐Loop Insulin Delivery in Inpatient Care: A Systematic Review and Meta‐Analysis of Clinical and Implementation Outcomes
Aims: Closed‐loop (CL) insulin delivery systems have transformed outpatient diabetes care. However, evidence supporting their role in inpatient settings is limited. This systematic review and meta‐analysis evaluated the safety, efficacy, and implementation of CL systems in inpatient care. Materials and Methods: This review followed PRISMA guidelines (PROSPERO: CRD420251133486). Eligible studies reported glycaemic, safety, and/or implementation outcomes for adults managed with CL systems in inpatient care. EMBASE, PubMed, MEDLINE, Scopus, CINAHL, and Cochrane Library were searched from inception to August 2026. Risk of bias was assessed using RoB2 and ROBINS‐I. Random‐effects meta‐analysis evaluated glycaemic outcomes and length of stay (LOS). Results were presented as pooled mean differences (MDs) and 95% confidence intervals (CIs). Implementation data were analysed thematically. Intrapartum outcomes were analysed separately. Results: Thirteen inpatient studies were included, nine contributing to meta‐analysis. CL delivery increased time in range (MD +22.27%, 95% CI: 16.03–28.51; p < 0.001) and reduced time above range (MD −23.75%, 95% CI: −28.05 to −19.45; p < 0.001), mean glucose (MD −1.66 mmol/L, 95% CI: −2.29 to −1.03; p < 0.001) and glucose standard deviation (MD −0.64 mmol/L, 95% CI: −0.85 to −0.43; p < 0.001). No significant differences were observed in time below range, coefficient of variation or LOS. Total daily insulin dose was higher (MD +10.82 IU/day, 95% CI: 0.02–21.62; p = 0.05). No serious device‐attributed adverse events were reported. Implementation challenges included staff training, technical support, and workflow integration. Four additional intrapartum studies were included; two contributed to the meta‐analysis, showing increased pregnancy‐specific time in range (MD +11.82%, 95% CI: 5.56–18.08; p < 0.001). Conclusion: CL systems improve inpatient glycaemic control, although effects on LOS and comparative safety remain uncertain. Wider adoption requires sustainable technical and organisational support.
- 3 November 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
Open AccessClosed‐Loop Insulin Delivery in Inpatient Care: A Systematic Review and Meta‐Analysis of Clinical and Implementation Outcomes
Aims: Closed‐loop (CL) insulin delivery systems have transformed outpatient diabetes care. However, evidence supporting their role in inpatient settings is limited. This systematic review and meta‐analysis evaluated the safety, efficacy, and implementation of CL systems in inpatient care. Materials and Methods: This review followed PRISMA guidelines (PROSPERO: CRD420251133486). Eligible studies reported glycaemic, safety, and/or implementation outcomes for adults managed with CL systems in inpatient care. EMBASE, PubMed, MEDLINE, Scopus, CINAHL, and Cochrane Library were searched from inception to August 2026. Risk of bias was assessed using RoB2 and ROBINS‐I. Random‐effects meta‐analysis evaluated glycaemic outcomes and length of stay (LOS). Results were presented as pooled mean differences (MDs) and 95% confidence intervals (CIs). Implementation data were analysed thematically. Intrapartum outcomes were analysed separately. Results: Thirteen inpatient studies were included, nine contributing to meta‐analysis. CL delivery increased time in range (MD +22.27%, 95% CI: 16.03–28.51; p < 0.001) and reduced time above range (MD −23.75%, 95% CI: −28.05 to −19.45; p < 0.001), mean glucose (MD −1.66 mmol/L, 95% CI: −2.29 to −1.03; p < 0.001) and glucose standard deviation (MD −0.64 mmol/L, 95% CI: −0.85 to −0.43; p < 0.001). No significant differences were observed in time below range, coefficient of variation or LOS. Total daily insulin dose was higher (MD +10.82 IU/day, 95% CI: 0.02–21.62; p = 0.05). No serious device‐attributed adverse events were reported. Implementation challenges included staff training, technical support, and workflow integration. Four additional intrapartum studies were included; two contributed to the meta‐analysis, showing increased pregnancy‐specific time in range (MD +11.82%, 95% CI: 5.56–18.08; p < 0.001). Conclusion: CL systems improve inpatient glycaemic control, although effects on LOS and comparative safety remain uncertain. Wider adoption requires sustainable technical and organisational support.
- Open Access
- 10 October 2026
- Published by Wiley in Diabetic Medicine
- p. e70488
Ethnicity is associated with variation in diabetes emergency outcomes: Findings from the DEKODE audit and feedback programme
Background: Although ethnic disparities in diabetes prevalence and chronic complications are well recognised, their association with acute metabolic emergencies and outcomes is not well established. In this study, we investigated the association between ethnicity and clinical outcomes. Methods: This retrospective multicentre study included adults (≥16 years) admitted with diabetic ketoacidosis (DKA), hyperosmolar hyperglycaemic state (HHS) and hypoglycaemia between 2020 and 2023 in participating centres of the Digital Evaluation of Ketosis and Other Diabetes Emergencies (DEKODE) surveillance programme. Ethnicity was grouped as White, Asian or Black. Multivariable linear and logistic regression models assessed associations between ethnicity and length of stay (LOS), episode duration and in‐hospital mortality, adjusting for demographic, biochemical and clinical covariates. Results: A total of 6859 episodes were analysed (4257 DKA; 191 HHS; 2411 hypoglycaemia). Across these, differences were observed in age at presentation, metabolic parameters, and LOS across ethnic groups. In DKA, Black and Asian ethnicities were associated with longer LOS than White ethnicity ( p < 0.001). Black ethnicity was also associated with prolonged DKA duration ( p = 0.006). In the HHS cohort, Asian ethnicity was associated with longer LOS ( p = 0.014) but lower in‐hospital mortality ( p = 0.002). In the hypoglycaemia cohort, Black ethnicity was associated with lower mortality ( p = 0.037). Conclusions: Ethnic variation was observed in the presentation and outcomes of diabetic emergencies. After adjustment for demographic and clinical factors, ethnicity remained associated with several outcomes. These findings support further investigation into social, healthcare and pre‐hospital factors that may contribute to observed differences.
- 10 October 2026
- Published by Wiley in Diabetic Medicine
- p. e70488
Open AccessEthnicity is associated with variation in diabetes emergency outcomes: Findings from the DEKODE audit and feedback programme
Background: Although ethnic disparities in diabetes prevalence and chronic complications are well recognised, their association with acute metabolic emergencies and outcomes is not well established. In this study, we investigated the association between ethnicity and clinical outcomes. Methods: This retrospective multicentre study included adults (≥16 years) admitted with diabetic ketoacidosis (DKA), hyperosmolar hyperglycaemic state (HHS) and hypoglycaemia between 2020 and 2023 in participating centres of the Digital Evaluation of Ketosis and Other Diabetes Emergencies (DEKODE) surveillance programme. Ethnicity was grouped as White, Asian or Black. Multivariable linear and logistic regression models assessed associations between ethnicity and length of stay (LOS), episode duration and in‐hospital mortality, adjusting for demographic, biochemical and clinical covariates. Results: A total of 6859 episodes were analysed (4257 DKA; 191 HHS; 2411 hypoglycaemia). Across these, differences were observed in age at presentation, metabolic parameters, and LOS across ethnic groups. In DKA, Black and Asian ethnicities were associated with longer LOS than White ethnicity ( p < 0.001). Black ethnicity was also associated with prolonged DKA duration ( p = 0.006). In the HHS cohort, Asian ethnicity was associated with longer LOS ( p = 0.014) but lower in‐hospital mortality ( p = 0.002). In the hypoglycaemia cohort, Black ethnicity was associated with lower mortality ( p = 0.037). Conclusions: Ethnic variation was observed in the presentation and outcomes of diabetic emergencies. After adjustment for demographic and clinical factors, ethnicity remained associated with several outcomes. These findings support further investigation into social, healthcare and pre‐hospital factors that may contribute to observed differences.
- Open Access
- 14 July 2026
- Published by Springer Nature
Improving care for people admitted with diabetes-related emergencies
- 14 July 2026
- Published by Springer Nature
Open AccessImproving care for people admitted with diabetes-related emergencies
- Open Access
- 21 June 2026
- Published by Wiley in Diabetic Medicine
- p. e70399
Re: Clinically significant hypoglycaemia in hospitalised adults: A multicentre study of 1205 episodes in the United Kingdom
- 21 June 2026
- Published by Wiley in Diabetic Medicine
- p. e70399
Open AccessRe: Clinically significant hypoglycaemia in hospitalised adults: A multicentre study of 1205 episodes in the United Kingdom
- Open Access
- 17 June 2025
- Published by Wiley in Diabetic Medicine
- Vol. 42 (9) , e70068
Simulation‐based training significantly improved confidence and clinical skills of resident doctors in acute diabetes management
Aims: The joint consensus of the American Diabetes Association and the European Association for the Study of Diabetes highlights the need for practical, up‐to‐date training in acute diabetes care. Therefore, this session aimed to develop an applied learning intervention that identifies key gaps in acute diabetes training, assesses participants' change in confidence in managing these scenarios following the intervention and evaluates participants' satisfaction and the intervention's relevance to practice.Methods: To design the programme, we adopted Kern's six‐step curriculum development framework. Clinical experts were interviewed to assess general needs, and students and resident doctors were interviewed to assess targeted needs. The SIMBA (Simulation via Instant Messaging for Bedside Application) model was adopted to develop cases alongside generative AI and expert input. Pre‐ and post‐session surveys assessed participants' confidence, while the latter also assessed satisfaction and relevance to practice.Results: 33 participants attended the session. 17 participants completed both pre‐ and post‐session surveys and were included in the study. Simulation performance scores averaged 4.0/5 for history taking, interpretation and clinical judgement; 3.9/5 for physical examination and investigations; and 3.6/5 for management. Confidence in managing acute diabetes scenarios improved significantly (pre vs. post: 33.3% vs. 78.4%, p < 0.001). 94.1% strongly agreed the cases were relevant, and 82.3% preferred this teaching method over traditional approaches.Conclusion: The model identified the need for targeted education on physical examination, investigations and management specific to acute diabetes scenarios. Simulation‐based education significantly enhances confidence and is perceived as highly relevant for training in acute diabetes management.
- 17 June 2025
- Published by Wiley in Diabetic Medicine
- Vol. 42 (9) , e70068
Open AccessSimulation‐based training significantly improved confidence and clinical skills of resident doctors in acute diabetes management
Aims: The joint consensus of the American Diabetes Association and the European Association for the Study of Diabetes highlights the need for practical, up‐to‐date training in acute diabetes care. Therefore, this session aimed to develop an applied learning intervention that identifies key gaps in acute diabetes training, assesses participants' change in confidence in managing these scenarios following the intervention and evaluates participants' satisfaction and the intervention's relevance to practice.Methods: To design the programme, we adopted Kern's six‐step curriculum development framework. Clinical experts were interviewed to assess general needs, and students and resident doctors were interviewed to assess targeted needs. The SIMBA (Simulation via Instant Messaging for Bedside Application) model was adopted to develop cases alongside generative AI and expert input. Pre‐ and post‐session surveys assessed participants' confidence, while the latter also assessed satisfaction and relevance to practice.Results: 33 participants attended the session. 17 participants completed both pre‐ and post‐session surveys and were included in the study. Simulation performance scores averaged 4.0/5 for history taking, interpretation and clinical judgement; 3.9/5 for physical examination and investigations; and 3.6/5 for management. Confidence in managing acute diabetes scenarios improved significantly (pre vs. post: 33.3% vs. 78.4%, p < 0.001). 94.1% strongly agreed the cases were relevant, and 82.3% preferred this teaching method over traditional approaches.Conclusion: The model identified the need for targeted education on physical examination, investigations and management specific to acute diabetes scenarios. Simulation‐based education significantly enhances confidence and is perceived as highly relevant for training in acute diabetes management.